Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Oxford COVID Vaccine Trial Group

Research output: Contribution to journalArticlepeer-review

442 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK'. Together they form a unique fingerprint.

Medicine & Life Sciences